Impaired platelet mitochondrial activity in Alzheimer's disease and mild cognitive impairment - Wikidata - wikimedia - TriplyDB

Impaired platelet mitochondrial activity in Alzheimer's disease and mild cognitive impairment

Impaired platelet mitochondrial activity in Alzheimer's disease and mild cognitive impairment

http://www.wikidata.org/entity/Q35781535

about

Insulin in central nervous system: more than just a peripheral hormone The Rationale for Insulin Therapy in Alzheimer's Disease Diverse molecular targets for therapeutic strategies in Alzheimer's disease Shift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventions Mitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic intervention Triad of Risk for Late Onset Alzheimer's: Mitochondrial Haplotype, APOE Genotype and Chromosomal Sex Polymorphic variation in cytochrome oxidase subunit genes.Decreased platelet APP isoform ratios in autosomal dominant Alzheimer's disease: baseline data from a DIAN cohort subset.Estrogen: a master regulator of bioenergetic systems in the brain and body Adverse stress, hippocampal networks, and Alzheimer's disease.Abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease.The Alzheimer's disease mitochondrial cascade hypothesis The neurodegenerative mitochondriopathies.APOE and neuroenergetics: an emerging paradigm in Alzheimer's disease.Oxidative stress and amyloid-beta pathology in normal individuals with a maternal history of Alzheimer's.Brain diabetic neurodegeneration segregates with low intrinsic aerobic capacity Platelets, a reliable source for peripheral Alzheimer's disease biomarkers?Maternal transmission of Alzheimer's disease: prodromal metabolic phenotype and the search for genes.Insulin-resistant brain state: the culprit in sporadic Alzheimer's disease?Reduced posterior cingulate mitochondrial activity in expired young adult carriers of the APOE ε4 allele, the major late-onset Alzheimer's susceptibility gene Oxidative stress-mediated activation of extracellular signal-regulated kinase contributes to mild cognitive impairment-related mitochondrial dysfunction Brain aging, Alzheimer's disease, and mitochondria.Reduced mitochondria cytochrome oxidase activity in adult children of mothers with Alzheimer's disease.Amyloid-Related Memory Decline in Preclinical Alzheimer's Disease Is Dependent on APOE ε4 and Is Detectable over 18-Months.Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease.Role of mitochondrial homeostasis and dynamics in Alzheimer's disease.Ginsenoside Rg1 attenuates oligomeric Aβ(1-42)-induced mitochondrial dysfunction.PET sheds light on Alzheimer's disease genetic risk Mitochondrial Alterations in Peripheral Mononuclear Blood Cells from Alzheimer's Disease and Mild Cognitive Impairment Patients.Mitochondria in neurodegeneration.Increased Electron Paramagnetic Resonance Signal Correlates with Mitochondrial Dysfunction and Oxidative Stress in an Alzheimer's disease Mouse Brain Mitochondrial DNA oxidative damage and repair in aging and Alzheimer's disease.Clinical implications from proteomic studies in neurodegenerative diseases: lessons from mitochondrial proteins.Broad-based nutritional supplementation in 3xTg mice corrects mitochondrial function and indicates sex-specificity in response to Alzheimer's disease intervention.The Alzheimer's disease mitochondrial cascade hypothesis: an update Mitochondrial approaches for neuroprotection Glucose metabolism in normal aging and Alzheimer's disease: Methodological and physiological considerations for PET studies.Mitochondria: a therapeutic target in neurodegeneration Role of mitochondrial-mediated signaling pathways in Alzheimer disease and hypoxia.Mitochondrial medicine for neurodegenerative diseases.

P2860

Q21296648-C04F94C2-160A-4D10-9ACE-1D01052F902D Q26744834-4E140496-BA2F-4874-A6D9-77F30C83B414 Q26827193-C87A19CB-A39B-417E-AF2D-FBF40D16BE10 Q26830740-8F79BA2B-73BB-4F11-A3A0-2CD0D2F7AE38 Q26865358-1A7B979B-4AEE-4F9E-AC5D-2E209179DD00 Q28077056-8B4553B1-7D72-4B0B-A409-599CC9C9E8F8 Q30435387-9C5442B8-7AC1-43D3-A23D-0F4B542B9AE3 Q30887981-A87A21C4-0F5E-4AE2-A3D8-43F60AF19EE1 Q33623924-D2149E54-8F9B-43B6-A258-DEAD0B90E5FB Q33708011-4E9A875D-492B-4D11-9582-141F11D56D8D Q33897771-1080F1B6-495C-4F71-99CE-BF997E4DB333 Q33905871-B6816AB3-6B9C-4A37-BF3E-0351CCB20D18 Q33957065-CA7346BC-C0D6-428F-A40C-EDDFEFEA8760 Q34034409-D42AE480-D0CE-44D7-AFCB-F3C3E013B17B Q34258737-5A07E8FC-89A2-4F02-A5A4-15E42C8695B2 Q34286417-5717F502-1403-470C-AB4E-958AA6DD5F0F Q34500658-27894B60-93A9-400E-A70D-14C48E610CD2 Q34552263-4A81DFFB-E867-404E-B660-57D09DF25BEB Q34669518-4B6B1E42-EABC-45CD-82E9-FA8D64A36050 Q35072027-CF8BCBE4-0B1E-4411-9A67-EFF310031177 Q35358475-2D260F14-54C6-4C5A-8B1F-90FE474F39EE Q35533354-93F48D4C-E8EA-4703-8695-688482C9EC07 Q35795672-9A0412E2-39E8-451B-BEA9-6CD98B58EE56 Q35796631-B9A5D9F1-7276-4DA7-8BBD-CEC0166145F7 Q35898628-768F5B6A-2B15-4421-9416-A112240CB0B7 Q35916588-37D3D7F1-8233-45C5-A2E8-D646E173A5A0 Q36054716-17E993CE-EFB1-42C3-928B-2328D35F3B68 Q36277092-2CE63FC0-6273-4910-8D23-10593B0E15E6 Q36531568-91D3CDDC-80EA-44D8-8CD6-4B6D1182C925 Q36745271-672DD2A9-CBAD-4ABC-AB31-7D0444184AA1 Q36820939-CF8EDA89-7B33-4196-97E0-F0474D572822 Q36900007-A0C52B3D-F876-4301-9614-0A5E472957AD Q37105161-46A551ED-89AC-4E69-9420-394DC6AA9425 Q37175697-BA9BA91D-A722-4D99-8401-C094A89FD27B Q37261159-3D6ECBFC-B28C-46D8-8DCD-A761316B60C0 Q37348590-6E271450-F940-4522-93A6-ACC7F2F317F5 Q37436607-CE319D17-4293-4203-A10D-9E35B05391DE Q37466059-4FE3925C-907B-41CF-A61D-400A78C68B02 Q37615142-03A2E9CF-F787-4F51-BA51-9B4EC76FD302 Q37672741-EA9F7DD4-C35B-4331-92B8-9AC5F9D60656

P2860

Impaired platelet mitochondrial activity in Alzheimer's disease and mild cognitive impairment

http://www.wikidata.org/entity/Q35781535

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Impaired platelet mitochondria ...... and mild cognitive impairment

@ast

Impaired platelet mitochondria ...... and mild cognitive impairment

@en

type

label

Impaired platelet mitochondria ...... and mild cognitive impairment

@ast

Impaired platelet mitochondria ...... and mild cognitive impairment

@en

prefLabel

Impaired platelet mitochondria ...... and mild cognitive impairment

@ast

Impaired platelet mitochondria ...... and mild cognitive impairment

@en

P1433

Q35781535-A3C87EFB-9141-4C7E-837E-8EB268D8C975

P1476

Q35781535-407D5BB9-8F61-4CF5-AEF7-614DCB128AC8

P2093

Q35781535-1D72B627-F39D-4727-B2D5-76101F5C28D4

Q35781535-23176E64-D13A-4001-96E6-27029D81981C

Q35781535-335F22AB-806D-4FC1-9F4A-B0EAC2CEA5AE

Q35781535-49F7EF55-1415-4602-A4DE-0654DF484B7E

Q35781535-6A1D0361-FAF6-4E0E-9E5B-E9584BCEF928

Q35781535-A579A4FC-9029-4DF9-8457-D34691A68D44

Q35781535-D994F42D-84C5-42CC-A8D9-CD032C916716

Q35781535-DBA73CEA-AD6E-4F94-82E2-7208ECCA3319

Q35781535-DE655FD7-643E-44E7-9CA8-A45E4AF27925

Q35781535-ED97FF57-ADF3-4364-9199-02EBB9A062C2

P2860

Q35781535-00F429BD-ADEB-4EFC-89D6-2F0B91E0F066

Q35781535-036CF0ED-9099-4BCD-8B50-823144079793

Q35781535-0946857F-8C48-4C91-8DB5-246C7E7E8B65

Q35781535-130ECBE1-8504-407D-A236-071AD0A58FE8

Q35781535-14BA4739-D9E7-4BC2-A2EF-42EA8BC8141B

Q35781535-28473B60-68D6-491A-B0E6-DC61BEDE8AAC

Q35781535-373E61C8-668A-4546-9EE4-9433DDB132C9

Q35781535-3C2BF461-A860-42D2-B96E-61109C6405D2

Q35781535-3C42CA23-7847-463D-8456-72508C539CB4

Q35781535-3DCC96C6-5241-4154-81C3-3A7FD07DBAC2

P304

Q35781535-705B08EF-2D84-471C-82CF-98E2F3A875F5

P31

Q35781535-B5B30F44-798F-4176-BAAA-39318541258D

P356

Q35781535-90FB777D-CE06-4FF4-879A-733F80D4C836

P433

Q35781535-6E8F15C8-1F6B-459D-8692-703549C62682

P478

Q35781535-84E8FC00-33E0-47F9-A1E3-E4B9CD99B220

P50

Q35781535-D18FCB82-0E4B-4A6B-B336-E91FD1440C9E

P577

Q35781535-FE8FBBBD-8D27-4ACE-B9DC-F1B384A397C9

P5875

Q35781535-768C5121-DA0D-4C88-9FD8-F7203C25F59B

P698

Q35781535-021E9712-F4FC-4264-BD68-415110F9B8B5

P921

Q35781535-FAD25FC1-B79B-4C4B-A333-391CDA783A7F

P932

Q35781535-E5796862-88C7-482C-9864-6D86CD7DC247

P356

J.MITO.2006.10.004

P1433

P1476

Impaired platelet mitochondria ...... and mild cognitive impairment

@en

P2093

Douglas G Walker

http://www.w3.org/2001/XMLSchema#string

Gene Alexander

http://www.w3.org/2001/XMLSchema#string

Geoffrey L Ahern

http://www.w3.org/2001/XMLSchema#string

Jon Valla

http://www.w3.org/2001/XMLSchema#string

Keith D Coon

http://www.w3.org/2001/XMLSchema#string

Leslie Baxter

http://www.w3.org/2001/XMLSchema#string

Lonnie Schneider

http://www.w3.org/2001/XMLSchema#string

Marwan N Sabbagh

http://www.w3.org/2001/XMLSchema#string

Richard Caselli

http://www.w3.org/2001/XMLSchema#string

Tracy Niedzielko

http://www.w3.org/2001/XMLSchema#string

P2860

Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Mild cognitive impairment: clinical characterization and outcome

Association of ATP synthase alpha-chain with neurofibrillary degeneration in Alzheimer's disease

Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia

The Clinical Dementia Rating (CDR): current version and scoring rules

Abnormal mitochondrial morphology in sporadic Parkinson's and Alzheimer's disease cybrid cell lines.

Alzheimer's disease cybrids replicate beta-amyloid abnormalities through cell death pathways.

Mitochondrial abnormalities in cybrid cell models of sporadic Alzheimer's disease worsen with passage in culture.

Cytochrome c oxidase in Alzheimer's disease brain: purification and characterization.

P304

323-330

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.MITO.2006.10.004

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-10-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6674074

http://www.w3.org/2001/XMLSchema#string

P698

17123871

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

1864936

http://www.w3.org/2001/XMLSchema#string